Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Apr;68(4):757–763. doi: 10.1111/j.1476-5381.1980.tb10869.x

Prostaglandin action, release and inactivation by rat isolated perfused mesenteric blood vessels.

I M Coupar
PMCID: PMC2044243  PMID: 7378646

Abstract

1 The following experiments were undertaken to confirm that prostaglandin is necessary for noradrenaline to exert its full vasoconstrictor effect in rat mesenteric blood vessels. Prostaglandin release and inactivation were also studied. 2 The cyclo-oxygenase inhibitor, 5, 8, 11, 14-eicosatetraynoic acid caused a significant depression of the concentration-effect curve to noradrenaline. As with indomethacin, responses were restored to control levels by prostaglandin E2 (PGE2) but PGE2 did not restore responses to noradrenaline depressed by papaverine. 3 PGE2-like activity was released from tissues at rest, equivalent to 50 +/- 20 pg PGE2/min. The substance was probably a stable prostaglandin since activity remained on acidifying and extracting into chloroform. The increase in release stimulated by noradrenaline was reduced below resting values by indomethacin. 4 There was a net loss of 7 +/- 1 and 1 +/- 0.2 ng PGE2/min from tissues perfused with 40 and 4 ng/min PGE2 respectively. No uptake occurred at lower PGE2 perfusion rates. 5 When indomethacin was used to depress responses to noradrenaline 15(S)-15-methyl PGE2 methyl ester was 12 times more potent than PGE2 in restoring responses to control values. The cyclic endoperoxide analogue U-46619 caused only partial restoration of indomethacin-depressed responses to noradrenaline but increased perfusion pressure at 2 ng/ml and above. 6 The results confirm that endogenous prostaglandin release, possible of PGE2, is obligatory to the full vasoconstrictor effect of noradrenaline. Noradrenaline increases the amount of prostaglandin released which may be taken up and inactivated by 15-hydroxy prostaglandin dehydrogenase or beta-oxidase. U-46619 may mimic both PGE2 and thromboxane A2.

Full text

PDF
757

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter I., Kot P. A., Ramwell P. W., Rose J. C., Shnider M. R. Circulatory effects of prostaglandin endoperoxide analogues studied in the dog during left ventricular bypass. Br J Pharmacol. 1977 Nov;61(3):395–398. doi: 10.1111/j.1476-5381.1977.tb08431.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armstrong J. M., Blackwell G. J., Flower R. J., McGiff J. C., Mullane K. Proceedings: Possible contribution of prostaglandins to genetic hypertension in rats: identification of biochemical lesion. Br J Pharmacol. 1975 Oct;55(2):244P–244P. [PMC free article] [PubMed] [Google Scholar]
  3. Coupar I. M., McColl I. Stimulation of water and sodium secretion and inhibition of glucose absorption from the rat jejunum during intraarterial infusions of prostglandins. Gut. 1975 Oct;16(10):759–765. doi: 10.1136/gut.16.10.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coupar I. M., McLennan P. L. The influence of prostaglandins on noradrenaline-induced vasoconstriction isolated perfused mesenteric blood vessels of the rat. Br J Pharmacol. 1978 Jan;62(1):51–59. doi: 10.1111/j.1476-5381.1978.tb07005.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ferreira S. H., De Souza Costa F. A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances. Eur J Pharmacol. 1976 Oct;39(2):379–381. doi: 10.1016/0014-2999(76)90147-3. [DOI] [PubMed] [Google Scholar]
  6. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  7. Hamamdzić M., Malik K. U. Prostaglandins in adrenergic transmission of isolated perfused rat pancreas. Am J Physiol. 1977 Feb;232(2):E201–E209. doi: 10.1152/ajpendo.1977.232.2.E201. [DOI] [PubMed] [Google Scholar]
  8. Hamberg M., Hedqvist P., Strandberg K., Svensson J., Samuelsson B. Prostaglandin endoperoxides IV. Effects on smooth muscle. Life Sci. 1975 Feb 1;16(3):451–462. doi: 10.1016/0024-3205(75)90266-0. [DOI] [PubMed] [Google Scholar]
  9. Horrobin D. F., Manku M. S., Karmali R., Nassar B. A., Davies P. A. Aspirin, indomethacin, catecholamine and prostaglandin interactions on rat arterioles and rabbit hearts. Nature. 1974 Aug 2;250(465):425–426. doi: 10.1038/250425a0. [DOI] [PubMed] [Google Scholar]
  10. Kondo K., Misumi J., Okuno T., Nakamura R., Saruta T., Kato E. Effect of prostaglandin E2 on vascular reactivity to norepinephrine in isolated rat mesenteric artery, hind limb and splenic artery. Prostaglandins Med. 1979 Jan;2(1):67–75. doi: 10.1016/s0161-4630(79)80010-5. [DOI] [PubMed] [Google Scholar]
  11. MCGREGOR D. D. THE EFFECT OF SYMPATHETIC NERVE STIMULATION OF VASOCONSTRICTOR RESPONSES IN PERFUSED MESENTERIC BLOOD VESSELS OF THE RAT. J Physiol. 1965 Mar;177:21–30. doi: 10.1113/jphysiol.1965.sp007572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Malik K. U., McGiff J. C. Modulation by prostaglandins of adrenergic transmission in the isolated perfused rabbit and rat kidney. Circ Res. 1975 May;36(5):599–609. doi: 10.1161/01.res.36.5.599. [DOI] [PubMed] [Google Scholar]
  13. Malik K. U., McGiff J. C. Relationship of glucose metabolism to adrenergic transmission in rat mesenteric arteries. Effects of glucose deprivation, glucose metabolites, and changes in ionic composition on adrenergic mechanisms. Circ Res. 1974 Oct;35(4):553–574. doi: 10.1161/01.res.35.4.553. [DOI] [PubMed] [Google Scholar]
  14. Malik K. U., Ryan P., McGiff J. C. Modification by prostaglandins E1 and E2, indomethacin, and arachidonic acid of the vasoconstrictor responses of the isolated perfused rabbit and rat mesenteric arteries to adrenergic stimuli. Circ Res. 1976 Aug;39(2):163–168. doi: 10.1161/01.res.39.2.163. [DOI] [PubMed] [Google Scholar]
  15. Manku M. S., Horrobin D. F. Indomethacin inhibits responses to all vasoconstrictors in the rat mesenteric vascular bed: restoration of responses by prostaglandin E2. Prostaglandins. 1976 Sep;12(3):369–376. doi: 10.1016/0090-6980(76)90017-4. [DOI] [PubMed] [Google Scholar]
  16. Strand J. C., Miller M. P., McGiff J. C. Biological activity of the methyl esters of prostaglandin E2 and its (15S)-15-methyl analogue. Eur J Pharmacol. 1974 May;26(2):151–157. doi: 10.1016/0014-2999(74)90221-0. [DOI] [PubMed] [Google Scholar]
  17. Unger W. G., Stamford I. F., Bennett A. Extraction of prostaglandins from human blood. Nature. 1971 Oct 1;233(5318):336–337. doi: 10.1038/233336b0. [DOI] [PubMed] [Google Scholar]
  18. Weeks J. R., DuCharme D. W., Magee W. E., Miller W. L. The biological activity of the (15S)-15-methyl analogs of prostaglandins. E2 and F2a. J Pharmacol Exp Ther. 1973 Jul;186(1):67–74. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES